Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$670,256
-$147,354 QoQ
Shares Held
5,216
-23.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#2,451
of 3,769 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $9,612,551 across 15 Drug Manufacturers - General names. MRK ranks #3 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
3,869 | $4,640,595 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
7,901 | $998,212 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
5,216 | $670,256 | |
| 4 | BIIB |
Biogen Inc.
|
2,930 | $633,055 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
10,844 | $624,831 | |
| 6 | AZN |
Astrazeneca PLC
|
2,976 | $564,309 | |
| 7 | AMGN |
Amgen Inc
|
1,185 | $429,112 | |
| 8 | GRFS |
Grifols SA
|
31,637 | $223,989 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $670,256 | 5,216 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $817,610 | 6,797 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $630,717 | 5,992 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $514,301 | 6,497 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $620,330 | 6,911 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $687,505 | 6,911 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $507,613 | 4,470 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $644,379 | 5,205 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $589,816 | 4,470 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $567,448 | 5,205 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $667,218 | 6,481 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $763,535 | 6,617 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $753,985 | 7,087 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $1,158,982 | 10,446 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $556,765 | 6,465 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $576,832 | 6,327 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $633,015 | 7,715 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $480,532 | 6,270 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $304,720 | 4,057 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $315,512 | 4,057 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $191,799 | 2,488 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $203,517 | 2,488 | Shares | Sole | 2021-02-16 | |
| 2020-06-30 | $192,397 | 2,488 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $268,365 | 3,488 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||